Preliminary report

Hepatic fat and inflammation in type 2 diabetes mellitus

Aramesh Saremi, Matthew Allison, Dominic Ditomasso, Ling Ge, Robert J. Anderson, Tom E. Moritz, William Duckworth, Carlos Abraira, Peter D. Reaven

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Although the association between inflammation and hepatic fat is fairly established, it remains unclear whether this association is independent of general measures of obesity and standard cardiovascular risk factors. Therefore, the aim of this study was to investigate the contribution of hepatic steatosis as an independent predictor of chronic inflammation in 281 subjects with type 2 diabetes mellitus. Reduced hepatic steatosis significantly (P <.01) correlated with C-reactive protein (r = -0.16) and adiponectin (r = 0.23). The association of hepatic steatosis with both C-reactive protein and adiponectin remained significant after adjustment for age, ethnicity, body mass index (or waist circumference), triglycerides, high-density lipoprotein, and total cholesterol. These data support the concept that accumulation of hepatic fat is related to enhanced inflammation in type 2 diabetes mellitus independent of general measures of obesity and standard cardiovascular risk factors.

Original languageEnglish
Pages (from-to)430-432
Number of pages3
JournalMetabolism: Clinical and Experimental
Volume59
Issue number3
DOIs
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Fats
Inflammation
Liver
Adiponectin
C-Reactive Protein
Obesity
Waist Circumference
HDL Cholesterol
Triglycerides
Body Mass Index

All Science Journal Classification (ASJC) codes

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Preliminary report : Hepatic fat and inflammation in type 2 diabetes mellitus. / Saremi, Aramesh; Allison, Matthew; Ditomasso, Dominic; Ge, Ling; Anderson, Robert J.; Moritz, Tom E.; Duckworth, William; Abraira, Carlos; Reaven, Peter D.

In: Metabolism: Clinical and Experimental, Vol. 59, No. 3, 03.2010, p. 430-432.

Research output: Contribution to journalArticle

Saremi, A, Allison, M, Ditomasso, D, Ge, L, Anderson, RJ, Moritz, TE, Duckworth, W, Abraira, C & Reaven, PD 2010, 'Preliminary report: Hepatic fat and inflammation in type 2 diabetes mellitus', Metabolism: Clinical and Experimental, vol. 59, no. 3, pp. 430-432. https://doi.org/10.1016/j.metabol.2009.07.041
Saremi, Aramesh ; Allison, Matthew ; Ditomasso, Dominic ; Ge, Ling ; Anderson, Robert J. ; Moritz, Tom E. ; Duckworth, William ; Abraira, Carlos ; Reaven, Peter D. / Preliminary report : Hepatic fat and inflammation in type 2 diabetes mellitus. In: Metabolism: Clinical and Experimental. 2010 ; Vol. 59, No. 3. pp. 430-432.
@article{704dc6d857c44f56a19cedfb75bae1f6,
title = "Preliminary report: Hepatic fat and inflammation in type 2 diabetes mellitus",
abstract = "Although the association between inflammation and hepatic fat is fairly established, it remains unclear whether this association is independent of general measures of obesity and standard cardiovascular risk factors. Therefore, the aim of this study was to investigate the contribution of hepatic steatosis as an independent predictor of chronic inflammation in 281 subjects with type 2 diabetes mellitus. Reduced hepatic steatosis significantly (P <.01) correlated with C-reactive protein (r = -0.16) and adiponectin (r = 0.23). The association of hepatic steatosis with both C-reactive protein and adiponectin remained significant after adjustment for age, ethnicity, body mass index (or waist circumference), triglycerides, high-density lipoprotein, and total cholesterol. These data support the concept that accumulation of hepatic fat is related to enhanced inflammation in type 2 diabetes mellitus independent of general measures of obesity and standard cardiovascular risk factors.",
author = "Aramesh Saremi and Matthew Allison and Dominic Ditomasso and Ling Ge and Anderson, {Robert J.} and Moritz, {Tom E.} and William Duckworth and Carlos Abraira and Reaven, {Peter D.}",
year = "2010",
month = "3",
doi = "10.1016/j.metabol.2009.07.041",
language = "English",
volume = "59",
pages = "430--432",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Preliminary report

T2 - Hepatic fat and inflammation in type 2 diabetes mellitus

AU - Saremi, Aramesh

AU - Allison, Matthew

AU - Ditomasso, Dominic

AU - Ge, Ling

AU - Anderson, Robert J.

AU - Moritz, Tom E.

AU - Duckworth, William

AU - Abraira, Carlos

AU - Reaven, Peter D.

PY - 2010/3

Y1 - 2010/3

N2 - Although the association between inflammation and hepatic fat is fairly established, it remains unclear whether this association is independent of general measures of obesity and standard cardiovascular risk factors. Therefore, the aim of this study was to investigate the contribution of hepatic steatosis as an independent predictor of chronic inflammation in 281 subjects with type 2 diabetes mellitus. Reduced hepatic steatosis significantly (P <.01) correlated with C-reactive protein (r = -0.16) and adiponectin (r = 0.23). The association of hepatic steatosis with both C-reactive protein and adiponectin remained significant after adjustment for age, ethnicity, body mass index (or waist circumference), triglycerides, high-density lipoprotein, and total cholesterol. These data support the concept that accumulation of hepatic fat is related to enhanced inflammation in type 2 diabetes mellitus independent of general measures of obesity and standard cardiovascular risk factors.

AB - Although the association between inflammation and hepatic fat is fairly established, it remains unclear whether this association is independent of general measures of obesity and standard cardiovascular risk factors. Therefore, the aim of this study was to investigate the contribution of hepatic steatosis as an independent predictor of chronic inflammation in 281 subjects with type 2 diabetes mellitus. Reduced hepatic steatosis significantly (P <.01) correlated with C-reactive protein (r = -0.16) and adiponectin (r = 0.23). The association of hepatic steatosis with both C-reactive protein and adiponectin remained significant after adjustment for age, ethnicity, body mass index (or waist circumference), triglycerides, high-density lipoprotein, and total cholesterol. These data support the concept that accumulation of hepatic fat is related to enhanced inflammation in type 2 diabetes mellitus independent of general measures of obesity and standard cardiovascular risk factors.

UR - http://www.scopus.com/inward/record.url?scp=76249089657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76249089657&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2009.07.041

DO - 10.1016/j.metabol.2009.07.041

M3 - Article

VL - 59

SP - 430

EP - 432

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 3

ER -